BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3703233)

  • 1. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
    Théron J; Villemure JG; Worthington C; Tyler JL
    Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
    Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
    Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.
    Tyler JL; Yamamoto YL; Diksic M; Théron J; Villemure JG; Worthington C; Evans AC; Feindel W
    J Nucl Med; 1986 Jun; 27(6):775-80. PubMed ID: 3486962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 5. Superselective injection of BCNU through a latex calibrated-leak balloon.
    Debrun GM; Davis KR; Hochberg FH
    AJNR Am J Neuroradiol; 1983; 4(3):399-400. PubMed ID: 6410755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital angiographic changes after intracarotid BCNU chemotherapy.
    Gebarski SS; Greenberg HS; Gabrielsen TO; Vine AK
    AJNR Am J Neuroradiol; 1984; 5(1):55-8. PubMed ID: 6421125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual system toxicity following intra-arterial chemotherapy.
    Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
    Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
    Kapp JP; Sanford RA
    Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.
    Greenberg HS; Ensminger WD; Seeger JF; Kindt GW; Chandler F; Doan K; Dakhil SR
    Cancer Treat Rep; 1981; 65(9-10):803-10. PubMed ID: 7023671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
    Vance RB; Kapp JP
    J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain necroses after intraarterial chemotherapy and irradiation of malignant gliomas--a complication of both ACNU and BCNU?
    Tonn JC; Roosen K; Schachenmayr W
    J Neurooncol; 1991 Dec; 11(3):241-2. PubMed ID: 1823343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Internal carotid arterial BCNU perfusion in the treatment of cerebral glioma].
    Wu ZL
    Zhonghua Wai Ke Za Zhi; 1989 Jul; 27(7):421-3, 446. PubMed ID: 2598744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.
    Mahaley MS; Whaley RA; Blue M; Bertsch L
    J Neurooncol; 1986; 3(4):297-314. PubMed ID: 3958776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
    Kapp JP; Vance RB
    J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-arterial BCNU chemotherapy for malignant gliomas.
    Foo SH; Ransohoff J; Berenstein A; Choy IS
    J Neurosurg; 1985 Mar; 62(3):458-9. PubMed ID: 3973716
    [No Abstract]   [Full Text] [Related]  

  • 18. Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.
    Pickrell L; Purvin V
    J Clin Neuroophthalmol; 1987 Jun; 7(2):87-92. PubMed ID: 2956289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.
    Takeda N; Diksic M
    J Neurooncol; 1999 Feb; 41(3):235-46. PubMed ID: 10359143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.
    Clayman DA; Wolpert SM; Heros DO
    AJNR Am J Neuroradiol; 1989; 10(4):767-71. PubMed ID: 2549772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.